Turning genes on and off is like flipping a light switch, controlling whether genes in a cell are active. When a gene is ...

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. CRISPR Therapeutics AG stands among them. CRISPR Therapeutics AG (NASDAQ:CRSP) is a pioneering ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...

Scientists developed a new nanostructure that triples CRISPR’s ability to enter cells, unlocking even more power to treat ...

CRISPR-Cas9 technology has revolutionized biotechnology by providing an efficient, precise, and versatile tool for genome editing. This RNA-guided system allows scientists to target specific DNA ...

Discover the top CRISPR companies driving innovation in gene editing, from biotech pioneers to promising start-ups shaping ...

The colonies of Escherichia coli sitting in this petri dish become pathogenic when they carry Shiga toxin genes. Credit: Shutterstock “We’re essentially converting a pathogenic strain into a ...

In a development that could help protect one of the world's most beloved agricultural commodities, a research team at Penn ...

CRISPR Therapeutics (CRSP) has been making waves lately, especially after announcing promising early clinical data for its CTX310 program, a gene-editing therapy aimed at tackling cardiovascular ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the 10 Stocks Going Wild. Crispr Therapeutics rallied for a second day on Wednesday, adding 9.6 percent to close at $60.08 apiece, tracking the rally in ...

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds ...